Invision Sally Jobe Breast Imaging Expert Calls New Screening Mammography Guidelines 'A Step Backward'

Tuesday, November 17, 2009 General News J E 4

DENVER, Colo. -- Lora D. Barke, D.O., medical director of the Invision Sally Jobe Breast Network, is critical of new breast cancer screening guidelines issued Monday by the U.S. Preventive Services Task Force (USPSTF).

"This is really a step backward in the fight against breast cancer," said Barke, who oversees one of the largest breast imaging centers in the nation. "We'll end up diagnosing later stage cancer, which means more drug therapy, more radiation therapy and more late-stage intervention."

The new U.S. guidelines recommend against routine mammograms for women in their 40s. Barke, who oversees breast imaging services at Invision Sally Jobe's network of 11 Denver metro imaging centers, believes the new guidelines will only lead to confusion, mistrust and avoidance of regular breast cancer screening for all women.

"We're sticking with current American Cancer Society screening recommendations, which rely on a much more careful and thorough examination of the evidence than does the USPSTF," explained Barke.

Barke said the USPSTF's own evidence review concludes that mammography reduces the risk of dying in women in their 40s and 50s at about the same rate, and modern studies show that the risk of dying of breast cancer in women diagnosed in their 40s is reduced by 35 to 44 percent, not 15 percent as the USPSTF analysis reported.

About Invision Sally Jobe

Invision Sally Jobe is a network of medical imaging centers that offers full-service diagnostic imaging in several convenient Denver metro locations. Services include state-of-the-art MRI, CT, digital mammography, diagnostic X-ray, ultrasound, pain management, NIVA and osteoporosis testing. The Invision Sally Jobe Breast Network is Colorado's only Certified Quality Breast Center. Invision Sally Jobe is a joint venture with HealthOne and Radiology Imaging Associates and is committed to excellence in service to patients and referring physicians. Call 303-761-9190 or visit for more information.

/PRNewswire -- Nov. 17/

Media Contacts: Armada Medical Marketing Dan Snyders 303-623-1190 (x230) 720-231-9990 (cell)

SOURCE Invision Sally Jobe


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Smith & Nephew Endoscopy Announces Availability of...
Zyomyx Point-of-Care CD4 Test Selected by CD4 Init...